AFLURIA QUADRIVALENT (Seqirus Pty Ltd)


Welcome to the PulseAid listing for the AFLURIA QUADRIVALENT drug offered from Seqirus Pty Ltd. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: Seqirus Pty Ltd
NON-PROPRIETARY NAME: INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VI
SUBSTANCE NAME: INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VI
TYPE: VACCINE
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2016-09-28
END MARKETING DATE: 0000-00-00


AFLURIA QUADRIVALENT VACCINE Details:

Item DescriptionAFLURIA QUADRIVALENT from Seqirus Pty Ltd
LABELER NAME: Seqirus Pty Ltd
DEA SCHEDULE:
ACTIVE STRENGTH: 15; 15; 15; 15(ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL)
START MARKETING DATE: 2016-09-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 33332-317_05e139ee-fc74-481e-be2b-8dbaa34390b0
PRODUCT NDC: 33332-317
APPLICATION NUMBER: BLA125254

Other INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VI Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Energique, Inc.Influenzinum
Ratis, LLCInfluenzinum
Seqirus Pty LtdAFLURIA